<DOC>
	<DOCNO>NCT02213887</DOCNO>
	<brief_summary>The purpose 9-day study determine : 1 . Pantoprazole modifies steady-state plasma concentration orally administer psychotropic medication include valproic acid , lithium , second-generation antipsychotic ( i.e. , aripiprazole , asenapine , clozapine , lurasidone , olanzapine , paliperidone , quetiapine , risperidone , ziprasidone ) 2 . Serum gastrin level change within week start stopping pantoprazole</brief_summary>
	<brief_title>Study Effects Pantoprazole Levels Prescribed Psychiatric Medications</brief_title>
	<detailed_description>Individuals psychiatric diagnosis may predispose gastroesophageal reflux disease widespread use alcohol , cigarette , certain psychotropic drug population . Consequently , often prescribe proton pump inhibitor . To knowledge , study conduct determine effect proton pump inhibitor plasma level psychotropic drug . The present clinical study assess effect pantoprazole pharmacokinetics valproic acid , lithium , second-generation antipsychotic .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Psychotropic Drugs</mesh_term>
	<criteria>Participants must fluent English Participants psychiatric diagnosis currently treat one follow medication : valproic acid , lithium , secondgeneration antipsychotic ( i.e. , aripiprazole , asenapine , clozapine , lurasidone , olanzapine , paliperidone , quetiapine , risperidone , ziprasidone ) Participants stable dose valproic acid , lithium , and/or secondgeneration antipsychotic sufficient period time ensure steady state Participants symptom gastroesophageal reflux disease ( GERD ) would benefit treatment pantoprazole participant currently treat GERD pantoprazole 8 week currently symptom free . Participants hypersensitive pantoprazole Pregnant lactate woman Women childbearing age use reliable contraception Any postsurgical complication gastrointestinal tract might impair absorption Clinically relevant abnormality laboratory parameter Participants treat another acid suppress agent ( e.g. , H2 receptor antagonist , antacid , alginates , etc ) Participants treat atazanavir , delavirdine , erlotinib , nelfinavir , and/or posaconazole</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Drug Interactions</keyword>
	<keyword>Pantoprazole</keyword>
	<keyword>Proton Pump Inhibitors</keyword>
	<keyword>Psychotropic Drugs</keyword>
	<keyword>Antipsychotic Agents</keyword>
	<keyword>Aripiprazole</keyword>
	<keyword>Asenapine</keyword>
	<keyword>Clozapine</keyword>
	<keyword>Lurasidone</keyword>
	<keyword>Olanzapine</keyword>
	<keyword>9-hydroxy-risperidone</keyword>
	<keyword>Quetiapine</keyword>
	<keyword>Risperidone</keyword>
	<keyword>Ziprasidone</keyword>
	<keyword>Valproic Acid</keyword>
	<keyword>Lithium</keyword>
	<keyword>Gastrins</keyword>
	<keyword>Psychotic Disorders</keyword>
	<keyword>Gastroesophageal Reflux</keyword>
</DOC>